Hematology status update: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{Hudakarman}} | {{CMG}}; {{AE}} {{Hudakarman}} | ||
{{Organ System Project}} | {{Organ System Project}} | ||
System Leader: '''[[User:Ramyar Ghandriz|Ramyar Ghandriz, M.D.]]''' | System Leader: '''[[User:Ramyar Ghandriz|Ramyar Ghandriz, M.D.]]''' | ||
== Status Updates == | ==Status Updates== | ||
{| border="1" cellpadding="5" cellspacing="0" align="center" | | {| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | ||
|+ | |+ | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Resident survival guide Progress | ||
|- | |- | ||
|Completed | |Completed | ||
| | | | ||
|- | |- | ||
|In progress | |In progress | ||
| | | | ||
|- | |- | ||
|Remaining | |Remaining | ||
| | | | ||
|- | |- | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Primary care chapter Progress | ||
|- | |- | ||
|Completed | |Completed | ||
| | | | ||
|- | |- | ||
|In progress | |In progress | ||
| | | | ||
|- | |- | ||
|Remaining | |Remaining | ||
| | | | ||
|} | |} | ||
Line 34: | Line 35: | ||
! colspan="3" |Primary care resident survival guides | ! colspan="3" |Primary care resident survival guides | ||
|- | |- | ||
! Specialty | !Specialty | ||
! Topic | !Topic | ||
!Author | |||
!Status | |||
!Resident Survival Guide Page | |||
!Author | !Author | ||
!Status | !Status | ||
|- | |- | ||
|Hematology | |Hematology | ||
Line 58: | Line 59: | ||
| | | | ||
|- | |- | ||
| Hematology ||[[Anemia]] | |Hematology||[[Anemia]] | ||
| | | | ||
| ||[[Anemia resident survival guide]]|| Chetan ||Needs Review | | ||[[Anemia resident survival guide]]||Chetan||Needs Review | ||
|- | |- | ||
|Hematalogy | |Hematalogy | ||
Line 86: | Line 87: | ||
| | | | ||
|- | |- | ||
| Hematology ||[[Aplastic anemia]] | |Hematology||[[Aplastic anemia]] | ||
| | | | ||
| ||[[Aplastic anemia resident survival guide]]|| Chetan ||Needs Review | | ||[[Aplastic anemia resident survival guide]]||Chetan||Needs Review | ||
|- | |- | ||
| Hematology ||[[Hemolytic anemia]] | |Hematology||[[Hemolytic anemia]] | ||
| | | | ||
| ||[[Hemolytic anemia resident survival guide]]||Sanjana | | ||[[Hemolytic anemia resident survival guide]]||Sanjana | ||
|Needs English Review | |Needs English Review | ||
|- | |- | ||
| Hematology ||[[Heparin induced thrombocytopenia]] | |Hematology||[[Heparin induced thrombocytopenia]] | ||
| | | | ||
| ||[[HIT resident survival guide]]|| Karol|| Needs Review | | ||[[HIT resident survival guide]]||Karol||Needs Review | ||
|- | |- | ||
|Hematology | |Hematology | ||
Line 105: | Line 106: | ||
|[[Immune Thrombocytopenia resident survival guide]] | |[[Immune Thrombocytopenia resident survival guide]] | ||
|Iqra | |Iqra | ||
| | | - | ||
|- | |- | ||
|Hematology | |Hematology | ||
Line 123: | Line 124: | ||
| | | | ||
|- | |- | ||
| Hematology ||[[Pancytopenia]] | |Hematology||[[Pancytopenia]] | ||
| | | | ||
| ||[[Pancytopenia resident survival guide]]|| | | ||[[Pancytopenia resident survival guide]]|| || | ||
|- | |- | ||
| Hematology ||[[Thrombocytopenia]] | |Hematology||[[Thrombocytopenia]] | ||
| | | | ||
| ||[[Thrombocytopenia resident survival guide]]||Ogheneochuko|| Complete | | ||[[Thrombocytopenia resident survival guide]]||Ogheneochuko||Complete | ||
|- | |- | ||
| Hematology ||[[Febrile neutropenia]] | |Hematology||[[Febrile neutropenia]] | ||
| | | | ||
| ||[[Febrile neutropenia resident survival guide]]|| Rim ||Complete | | ||[[Febrile neutropenia resident survival guide]]||Rim||Complete | ||
|- | |- | ||
| Hematology ||[[Bleeding disorders]] | |Hematology||[[Bleeding disorders]] | ||
| | | | ||
| ||[[Bleeding disorder resident survival guide]]|| | | ||[[Bleeding disorder resident survival guide]]|| || | ||
|- | |- | ||
| Hematology ||[[DIC]] | |Hematology||[[DIC]] | ||
| | | | ||
| ||[[DIC resident survival guide]]||Ogheneochuko|| Complete | | ||[[DIC resident survival guide]]||Ogheneochuko||Complete | ||
|- | |- | ||
| Hematology ||[[Transfusion therapy]] | |Hematology||[[Transfusion therapy]] | ||
| | | | ||
| ||[[Transfusion therapy resident survival guide]]||Ayokunle||Complete | | ||[[Transfusion therapy resident survival guide]]||Ayokunle||Complete | ||
Line 150: | Line 151: | ||
==Status Update== | ==Status Update== | ||
{| border="1" cellpadding="5" cellspacing="0" align="center" | | {| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | ||
|+ | |+ | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Progress | ||
|- | |- | ||
|Completed | |Completed | ||
|4 | |4 | ||
|- | |- | ||
|In progress | |In progress | ||
|4 | |4 | ||
|- | |- | ||
|Remaining | |Remaining | ||
|16 | |16 | ||
|} | |} | ||
== List of Chapters Requiring Content == | ==List of Chapters Requiring Content== | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ||
Line 176: | Line 177: | ||
| rowspan="25" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology | | rowspan="25" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Acanthocytosis | *Acanthocytosis | ||
* | * | ||
Line 206: | Line 207: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[ACUITY HORIZONS bleeding criteria]] | *[[ACUITY HORIZONS bleeding criteria]] | ||
* | * | ||
Line 220: | Line 221: | ||
* | * | ||
*[[Purpura]] | *[[Purpura]] | ||
** Papular | **Papular | ||
** Infectious | **Infectious | ||
**[[Purpura fulminans]] | **[[Purpura fulminans]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 249: | Line 250: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Acute megakaryoblastic leukemia]] | *[[Acute megakaryoblastic leukemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 258: | Line 259: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*[[Neutrophilia]] | *[[Neutrophilia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 267: | Line 268: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Autoimmune lymphoproliferative syndrome]] | *[[Autoimmune lymphoproliferative syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 276: | Line 277: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*[[Lymphocytosis]] | *[[Lymphocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 285: | Line 286: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*[[Monocytosis]] | *[[Monocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 303: | Line 304: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Basophilia]] | *[[Basophilia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 312: | Line 313: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 321: | Line 322: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Castleman's disease]] | *[[Castleman's disease]] | ||
* | * | ||
Line 332: | Line 333: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Evans syndrome]] | *[[Evans syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 341: | Line 342: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Asplenia]] | *[[Asplenia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 431: | Line 432: | ||
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology | | rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Hemophilia]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Hemophilia]] | ||
*[[Hemophilia A (patient information)|Hemophilia A]] | *[[Hemophilia A (patient information)|Hemophilia A]] | ||
*[[Hemophilia B (patient information)|Hemophilia B]] | *[[Hemophilia B (patient information)|Hemophilia B]] | ||
Line 443: | Line 443: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |<br /> | | style="padding: 5px 5px; background: #F5F5F5;" |<br /> | ||
* [[22q11.2 deletion syndrome]] | *[[22q11.2 deletion syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ayushi Jane | | style="padding: 5px 5px; background: #F5F5F5;" |Ayushi Jane | ||
Line 452: | Line 452: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Anemia of prematurity]] | *[[Anemia of prematurity]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Asra Firdous | | style="padding: 5px 5px; background: #F5F5F5;" |Asra Firdous | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar | | style="padding: 5px 5px; background: #F5F5F5;" |Ramyar | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Complete | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 462: | Line 462: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Myelophthisic anemia]] | *[[Myelophthisic anemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mahda | | style="padding: 5px 5px; background: #F5F5F5;" |Mahda | ||
Line 471: | Line 471: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Diamond-Blackfan anemia]] | *[[Diamond-Blackfan anemia]] | ||
* | * | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Roghiae Marandi | | style="padding: 5px 5px; background: #F5F5F5;" |Roghiae Marandi | ||
Line 652: | Line 652: | ||
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology | | rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Antithrombin III deficiency]] | *[[Antithrombin III deficiency]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand, M.khuram afzal | | style="padding: 5px 5px; background: #F5F5F5;" |Sogand, M.khuram afzal | ||
Line 661: | Line 661: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Neutropenia]] | *[[Neutropenia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Daniel A. Gerber | | style="padding: 5px 5px; background: #F5F5F5;" |Daniel A. Gerber | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Complete | | style="padding: 5px 5px; background: #F5F5F5;" |Complete | ||
Line 670: | Line 670: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Cancer]] | *[[Cancer]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 680: | Line 680: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Fanconi anemia]] | *[[Fanconi anemia]] | ||
* | * |
Revision as of 19:52, 28 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Organ System Project |
---|
Topics |
Leaders & Members |
Meetings' Summary |
System Leader: Ramyar Ghandriz, M.D.
Status Updates
Resident survival guide Progress | |
---|---|
Completed | |
In progress | |
Remaining | |
Primary care chapter Progress | |
Completed | |
In progress | |
Remaining |
Primary Care
Status Update
Progress | |
---|---|
Completed | 4 |
In progress | 4 |
Remaining | 16 |
List of Chapters Requiring Content
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Hematology |
|
||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
In progress chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Hematology | Hemophilia | Assigned | Muhammad Adnan Heider | Abdelrahman | In progress | ||
Assigned | Ayushi Jane | Ramyar | In progress | ||||
Assigned | Asra Firdous | Ramyar | Complete | ||||
Assigned | Mahda | In progress | |||||
|
Assigned | Roghiae Marandi | Musadiq | In progress | |||
Completed chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Hematology | Sogand, M.khuram afzal | Complete | Needs Review | Ramyar | |||
Daniel A. Gerber | Complete | Needs Review | |||||
Complete | Needs Review | ||||||
|
Shayam Patel | Complete | Needs Review | ||||